THIRUVANANTHAPURAM: Insurance companies are increasingly using patients’ mental health treatment records to deny them claims ...

Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...

The inability to access mental health treatment can cause problems not only for the individual, but also for the businesses ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, ...

Alzamend Neuro to Present at Sequire Investor Summit; Company to Report Progress with Clinical Trials to be Initiated in 2025 and Expected Milestones ...

There are many journalists hiding from the stigma of mental health, addiction, or both, trying not to appear as damaged goods ...

Asterasis, a beauty medical device corporation, announced on the 15th that it recorded a subscription competition rate of ...

Rhea Chakraborty posted the episode of her upcoming show as she discussed the toughest phase of Yo Yo Honey Singh battling bipolar disorder. Check it out.

Johnson & Johnson and Intra-Cellular Therapies, Inc. have announced that they have entered into a definitive agreement under ...

Intra-Cellular’s clinical-stage pipeline is promising, with pipeline agents under development for a wide range of neurological indications.

Researchers are focused on identifying novel treatment modalities ... the industry includes anxiety disorder, ADHD, bipolar disorder, depression, eating disorder, post-traumatic stress disorder (PTSD) ...